1613530-52-1
Chemical Structure
2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine
- CAS No.: 1613530-52-1
- Formula:C18H22N2O10S
- Molecular Weight:458.44
IUPAC Name: (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(5-(2-methoxy-2-oxoethyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
InChIKey: RRMHOPJTBLCQOA-DNNBLBMLSA-N
SMILES: CC(O[C@H]1[C@@H](OC(C)=O)[C@H](N2C(NC(C(CC(OC)=O)=C2)=O)=S)O[C@@H]1COC(C)=O)=O
Biological Activity: 2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine | 2’,3’,5’-Tri-O-acetyl-5-methoxycarbonylmethyl-2-thiouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
